This inventor holds 2 USPTO granted patents. Top assignee: Spofa United Pharmaceutical Works. Active years: 1980-1982.
Company Filing History:
Years Active: 1980-1982
Title: Rudolf Kotva: Innovator in Pharmaceutical Chemistry
Introduction
Rudolf Kotva is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Kotva's work has had a meaningful impact on therapeutic developments.
Latest Patents
Kotva's latest patents include "Alkyl cyanomethyl ergoline-I derivatives and salts thereof" and "Derivatives of carboxyalkyl imino- and thioxo-barbituric acids." The first patent describes a procedure for preparing a novel group of alkyl cyanomethyl ergoline-I derivatives, which are characterized by their D-6-alkyl-8-cyanomethylergoline-I structure. These compounds have shown potential therapeutic effects, particularly in inhibiting tumor growth and extending the life of animals and humans. The second patent focuses on the preparation of 5-carboxyalkyl-2-iminobarbituric and 5-carboxyalkyl-2-thioxobarbituric acids, which are synthesized through a condensation process that yields compounds with significant therapeutic benefits.
Career Highlights
Rudolf Kotva is associated with Spofa United Pharmaceutical Works, where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have contributed to the creation of compounds that address critical health challenges.
Collaborations
Kotva has collaborated with notable colleagues such as Antonin Cerny and Miroslav Semonsky. Their combined expertise has fostered advancements in pharmaceutical chemistry and innovation.
Conclusion
Rudolf Kotva's contributions to pharmaceutical chemistry through his patents highlight his role as a significant inventor in the field. His work continues to influence therapeutic developments and improve health outcomes.